Animal Biotechnology Market Size & Growth Forecast 2027–2036, By Segments (Animal Type, End-use, Product, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Animal Biotechnology Market size was valued at USD 33.4 billion in 2026 and is anticipated to grow at a 9.41% CAGR from 2027 to 2036, surpassing USD 82.09 billion by 2036. The industry revenue for 2027 is calculated at USD 36.05 billion.
Get more details on this report
Request Free Sample ReportAnimal Biotechnology Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 36.04% share in 2026, supported by established animal health industries, veterinary technologies, and broad commercial adoption of precision solutions.
- Asia Pacific is projected to grow at an 11.3% CAGR, supported by livestock production needs, disease control initiatives, and expanding biotechnology adoption.
Segment Momentum
- Livestock leads the market because biotechnology is widely applied to improve food production efficiency, herd health, and breeding performance across large-scale production animals, delivering meaningful economic benefits.
- Veterinary hospitals are expanding fastest as advanced diagnostics, precision treatments, and modern disease management tools become increasingly integrated into routine clinical animal care.
Market Expansion Drivers
- Rising prevalence of animal diseases driving demand for advanced veterinary biotechnology solutions.
- Strengthening regulatory GMP standards improving veterinary biologics quality and compliance adoption.
- Expansion of livestock vaccine innovation and biologics accelerating animal healthcare modernization.
Leading Market Participants
- Top players in the animal biotechnology market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (United States), Elanco Animal Health Incorporated (United States), Virbac S.A. (France), IDEXX Laboratories, Inc. (United States), Dechra Pharmaceuticals PLC (United Kingdom), Heska Corporation (United States), Indian Immunologicals Limited (India), Biogénesis Bagó S.A. (Argentina).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 33.4 billion
- 2027 Estimated Market Size: USD 36.05 billion.
- Projected Market Size: USD 82.09 billion by 2036
- Growth Forecast: 9.41% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Livestock (Animal Type) | Research Institutes (End-use) | Vaccines (Product) | Preventive Care (Application)
- Emerging Opportunity Segment: Companion Animals (Animal Type) | Veterinary Hospitals (End-use) | Diagnostic Tests (Product) | Treatment (Application)
Market Growth Drivers and Industry Trends
Rising prevalence of animal diseases driving demand for advanced veterinary biotechnology solutions
The rising incidence of infectious and chronic diseases among livestock, companion animals, and other animal populations will drive the animal biotechnology market growth by increasing the need for more effective diagnostic, preventive, and therapeutic solutions. Conventional veterinary approaches may face limitations in addressing complex or emerging diseases, encouraging greater use of biotechnology-based diagnostics, recombinant products, molecular testing, and targeted therapies. Growing awareness among veterinarians, livestock producers, and animal health stakeholders regarding early disease identification and prevention is also supporting adoption of advanced biological solutions. In addition, the need to protect livestock productivity and maintain animal health is encouraging investment in technologies that can improve disease surveillance and treatment precision.
Strengthening regulatory GMP standards improving veterinary biologics quality and compliance adoption
Stronger good manufacturing practice (GMP) requirements are improving the quality, consistency, and safety of veterinary biological products, thereby supporting the animal biotechnology market as manufacturers increasingly prioritize compliant production processes. Regulatory emphasis on controlled manufacturing environments, quality assurance, process validation, traceability, and product testing is encouraging veterinary biologics producers to adopt more sophisticated production and quality-control capabilities. These standards also help reduce variability and contamination risks associated with vaccines, biological therapeutics, and other animal health products, increasing confidence among veterinary professionals and end users. As regulatory expectations become more rigorous, manufacturers are placing greater emphasis on standardized biotechnology platforms and validated production practices.
Expansion of livestock vaccine innovation and biologics accelerating animal healthcare modernization
Advancements in livestock vaccine development and biological therapies are accelerating modernization across animal healthcare systems, with the animal biotechnology market benefiting from broader adoption of innovative preventive and therapeutic approaches. New vaccine technologies can support more targeted protection against animal diseases while improving disease management across intensive farming and livestock production environments. The growing focus on preventive healthcare is also encouraging the development of biologics that can address evolving disease threats and improve herd health management. As livestock producers increasingly seek solutions that protect animal well-being while supporting productivity, innovation in vaccines, diagnostics, and other biotechnology-based products is strengthening the role of advanced biological technologies in veterinary care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of animal diseases driving demand for advanced veterinary biotechnology solutions | 2.30% | High | North America, Asia Pacific | High | Near Term |
| Strengthening regulatory GMP standards improving veterinary biologics quality and compliance adoption | 2.00% | High | North America, Europe | High | Near Term |
| Expansion of livestock vaccine innovation and biologics accelerating animal healthcare modernization | 1.70% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the animal biotechnology market with a 36.04% share in 2026, supported by advanced biotechnology research capabilities, sophisticated veterinary healthcare systems, and strong adoption of innovative animal health solutions. The region benefits from established research infrastructure and increasing emphasis on improving livestock productivity, disease management, breeding outcomes, and animal welfare. Continued integration of biotechnology into veterinary diagnostics, therapeutics, and reproductive applications is strengthening demand, while a mature agricultural and animal healthcare ecosystem provides a strong foundation for market development.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, driven by expanding livestock production, rising demand for animal-derived food products, and increasing attention to animal health and productivity. Improvements in veterinary infrastructure and growing awareness of biotechnology-based approaches are encouraging the adoption of advanced diagnostics, vaccines, reproductive technologies, and genetic solutions. Government and private-sector investments in agricultural modernization, combined with the need to address livestock diseases and improve production efficiency, are creating favorable conditions for regional expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Breeding SolutionsGermany is emphasizing precision breeding technologies supported by strong veterinary science and agricultural research capabilities. Organizations in Germany are adopting biotechnology tools that improve animal genetics while addressing productivity and responsible livestock management objectives.
France 🇫🇷
Sustainable Breeding PracticesFrance is integrating animal biotechnology with sustainable livestock production and advanced breeding initiatives. Stakeholders in France are focusing on biotechnology applications that improve genetic quality, animal welfare, and long-term efficiency across agricultural production systems.
Italy 🇮🇹
Veterinary Biotechnology AdoptionItaly is increasing the application of animal biotechnology across veterinary healthcare and livestock breeding programs. Organizations in Italy are adopting biotechnology-based diagnostics, reproductive technologies, and genetic improvement strategies to support efficient and resilient animal production.
Japan 🇯🇵
Advanced Animal HealthJapan is strengthening animal biotechnology through innovations in veterinary pharmaceuticals, reproductive technologies, and disease management. Companies in Japan are integrating biotechnology into livestock improvement programs that support efficient production and high animal health standards.
South Korea 🇰🇷
Genomic Livestock ProgramsSouth Korea is expanding animal biotechnology by applying genomic technologies and advanced breeding methods across livestock production. Research organizations and industry participants in South Korea are developing biotechnology solutions that improve herd performance and animal disease management.
United States 🇺🇸
Livestock Innovation PipelineThe U.S. continues to advance animal biotechnology through genetic improvement, animal health innovation, and reproductive technologies. Companies in the U.S. are investing in biotechnology platforms that enhance livestock productivity, disease resilience, and sustainable agricultural practices.
Segment Leadership and Growth Trends
Animal Biotechnology Market Share (%), by Animal Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Type Segment Analysis: Livestock (Largest Segment) vs Companion Animals (Fastest-Growing Segment)
Livestock represented the largest animal type segment in the animal biotechnology market in 2026, reflecting the extensive application of biotechnology across animal health, breeding, nutrition, and productivity enhancement. Genetic improvement, disease prevention, reproductive technologies, and efforts to improve animal efficiency are encouraging the adoption of advanced biotechnology solutions in livestock production. The growing focus on sustainable food production and maintaining animal health across large-scale farming systems further supports the segment's established market position.
In the animal biotechnology market, companion animals are witnessing faster growth as advances in veterinary diagnostics, genetics, therapeutics, and preventive care expand the scope of biotechnology applications. Increasing attention to animal wellness and individualized veterinary treatment is creating greater demand for sophisticated biological solutions. Improvements in diagnostic capabilities and growing adoption of advanced therapies are also encouraging veterinary professionals and pet owners to pursue more targeted approaches to managing companion animal health.
End-use Segment Analysis: Research Institutes (Largest Segment) vs Veterinary Hospitals (Fastest-Growing Segment)
Research institutes accounted for the largest share of the animal biotechnology market in 2026, supported by their central role in developing and validating new technologies for animal health, genetics, reproduction, and disease research. These institutions provide the infrastructure needed for laboratory investigation, experimental studies, and development of novel biotechnology applications. Continued scientific interest in improving animal productivity, disease resistance, and biological understanding sustains demand for advanced research platforms within this end-use segment.
Veterinary hospitals are emerging as the fastest-growing end-use segment as sophisticated biotechnology solutions increasingly move from research environments into routine animal healthcare. Greater availability of advanced diagnostics, genetic testing, and biologically based treatments is expanding the role of veterinary hospitals in technology adoption. Rising expectations for precise disease identification and individualized care are encouraging veterinary practitioners to incorporate more advanced biotechnology tools into clinical decision-making.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Livestock, Companion Animals | Livestock | Companion Animals |
| End-use | Veterinary Hospitals, Research Institutes, Others | Research Institutes | Veterinary Hospitals |
| Product | Vaccines, Drugs, Diagnostic Tests, Others | Vaccines | Diagnostic Tests |
| Application | Preventive Care, Treatment, Breeding, Others | Preventive Care | Treatment |
Competitive Landscape and Market Positioning
Major players in the animal biotechnology market:
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Merck & Co. Inc. (United States)
4. Elanco Animal Health Incorporated (United States)
5. Virbac S.A. (France)
6. IDEXX Laboratories Inc. (United States)
7. Dechra Pharmaceuticals PLC (United Kingdom)
8. Heska Corporation (United States)
9. Indian Immunologicals Limited (India)
10. Biogénesis Bagó S.A. (Argentina)
The animal biotechnology market is progressing through advancements in genetic engineering, disease diagnostics, and reproductive technologies aimed at improving animal health and productivity. Ongoing investments in biotechnology research are supporting the development of innovative solutions for livestock management and veterinary therapeutics. Expanding focus on sustainable food production and disease resistance is also driving technological evolution within the sector.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Merck & Co. Inc. (United States) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Virbac S.A. (France) | |||||||
| IDEXX Laboratories Inc. (United States) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom) | |||||||
| Heska Corporation (United States) | |||||||
| Indian Immunologicals Limited (India) | |||||||
| Biogénesis Bagó S.A. (Argentina). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| National Institute of Animal Biotechnology (NIAB) | Jan-25 | The NIAB inaugurated India’s first animal stem cell biobank and dedicated research laboratory in Hyderabad. This development establishes critical infrastructure for advancing regenerative biology and veterinary innovation, creating a foundation for future commercial applications in animal health, diagnostics, and the development of cultivated meat-related biotechnology platforms. |
| Praj Industries | Jan-25 | Praj Industries established an AI-enabled precision fermentation laboratory in Pune to support the industrial-scale deployment of biotechnology-based production platforms. By partnering with government stakeholders, the company is positioning itself to accelerate the commercialization of bio-based manufacturing, strengthening the overall innovation ecosystem for biotechnology applications in agricultural and industrial animal sectors. |
| Zoetis | Sep-24 | Global animal health leader Zoetis expanded its veterinary medicine and vaccine manufacturing facility in Hyderabad, India. This strategic infrastructure investment increases regional production capacity for advanced veterinary technologies, enabling more efficient supply chain operations to meet rising demand for specialized animal health products across the region. |
| Bioassay GmbH | Sep-24 | Bioassay GmbH received a GMP manufacturing license for its bioanalytical testing plant in Germany. The certification enables the facility to produce high-quality veterinary testing solutions, enhancing the company’s ability to meet rigorous regulatory standards and ensuring reliable supply chain capabilities for essential bioanalytical products within the European veterinary market. |
| Anvive Lifescience Inc. | Aug-24 | Anvive Lifescience Inc. secured a USD 33 million contract from the National Institute of Allergy and Infectious Diseases to develop a vaccine targeting Valley Fever in dogs. This investment underscores a strategic focus on expanding therapeutic options for fungal infections in the companion animal segment through government-supported research and development initiatives. |
| Fischer Medical Ventures | Aug-24 | Fischer Medical Ventures entered a strategic partnership with Bio Angle Vacs Sdn Bhd to develop and commercialize vaccines for livestock and aquaculture in India. This collaboration aims to mitigate high mortality rates by leveraging cross-border technological expertise, significantly enhancing the commercial availability of disease-prevention tools for the domestic agriculture and aquaculture sectors. |
| Akston Biosciences | Aug-24 | Akston Biosciences and Purdue University initiated a strategic drug co-development collaboration focusing on canine oncological complications. This partnership bridges academic research with clinical development, targeting high-growth areas in companion animal oncology and illustrating an industry-wide push to leverage specialized research collaborations for identifying and commercializing next-generation therapeutic solutions. |
| USFDA Center for Veterinary Medicine | Feb-24 | The USFDA’s Center for Veterinary Medicine launched the Animal and Veterinary Innovation Agenda to modernize regulatory pathways for novel therapies. By prioritizing emerging technologies such as gene editing and streamlining approval processes, this initiative aims to reduce market entry barriers and foster a more favorable environment for the commercialization of innovative veterinary products. |
| Bioceltix | Jan-24 | Polish biotech startup Bioceltix secured EUR 2.5 million (USD 2.7 million) in funding from European sources to advance research into biologics for canine diseases. This capital infusion supports the development of novel therapeutic pipelines, demonstrating increased investment interest in innovative, non-traditional treatment modalities for pets and companion animal healthcare. |
| Genics | Jan-24 | Australian veterinary biotech firm Genics introduced the Shrimp MultiPath 2.0 test kit, capable of detecting 18 distinct diseases in a single diagnostic application. This product launch represents a significant advancement in aquaculture health management, offering commercial scalability for disease surveillance and improving operational biosecurity for shrimp producers globally through high-throughput diagnostic technology. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Animal Biotechnology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Technology Platform | Molecular Biotechnology, Cell and Tissue Biotechnology, Reproductive Biotechnology, Genomic and Genetic Engineering Technologies |
| Distribution Channel | Direct Sales, Veterinary Distributors, Specialty Distributors, Online and Digital Channels |
| Value Chain Stage | Research and Discovery, Product Development and Validation, Commercial Production, Testing and Quality Control |
Animal Biotechnology Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Animal Health Innovation Pipeline Benchmark |
|
| Precision Livestock Adoption Readiness |
|
| Livestock Genetic Improvement Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of animal biotechnology?
What is the anticipated CAGR of the animal biotechnology industry?
How are animal disease management priorities influencing investment in animal biotechnology solutions?
How are regulatory standards and biologics innovation shaping the animal biotechnology market?
Why does the livestock segment lead the animal biotechnology market?
Why are veterinary hospitals the fastest-growing end-use segment in the animal biotechnology market?
Why does North America maintain leadership in the animal biotechnology market?
How is Asia Pacific driving future growth in animal biotechnology?
Which organizations are considered leaders in the animal biotechnology landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization